Drugmaker Dr. Reddy’s Laboratories said it launched a generic version of the Johnson & Johnson antibiotic Levaquin, which treats bacterial infections that cause bronchitis or pneumonia.
The Indian drugmaker will sell levofloxacin tablets in the United States in three doses: 250, 500, and 750 milligrams.
The antibiotic also treats infections of the skin, sinuses, kidney, bladder, and prostate.
Levaquin is made by Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of New Brunswick, N.J.-based Johnson & Johnson. It had about $1.1 billion in U.S. revenue for the most recent 12 months that ended in March, according to Dr. Reddy’s.
The Food and Drug Administration said it approved applications from 12 manufacturers for generic versions of the drug. Those companies also include Akorn Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA.
Date: June 22, 2011
Source: Associated Press
Filed Under: Drug Discovery